Quick Takeaways
- Curtis Gale Oltmans has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $132,455.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Curtis Gale Oltmans
- Location
- Boulder, CO
- Summary
- The estimated net worth of Curtis Gale Oltmans is at least $132,455 dollars as of 04 Feb 2026. Curtis Gale Oltmans is the Chief Legal Officer of Fulcrum Therapeutics, Inc. and owns shares of Fulcrum Therapeutics, Inc. (FULC) stock worth about $132.5K.
- Signature
- /s/ Curt Oltmans
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Curtis Gale Oltmans and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Fulcrum Therapeutics, Inc. ($132,455).
- Past-year value change for that position: -$44,600.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Curtis Gale Oltmans
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | Chief Legal Officer | $132,455 | -$44,600 | -25% | 02 Feb 2026 |
| ATXI | AVENUE THERAPEUTICS, INC. | Director | 23 Sep 2024 |
Insider Transactions Reported by Curtis Gale Oltmans:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.